| Acral Lentiginous Melanoma studied in …STUDIED_INderived16 of 16show fewer |
|---|
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462406Phase 2 · active not recruiting Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial · condition mapped CURATED_BROADER · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04511013Phase 2 · recruiting A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases · condition mapped ONTOLOGY_EXACT · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937937Phase 2 · active not recruiting Dinaciclib in Treating Patients With Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ONTOLOGY_EXACT · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698019Phase 2 · active not recruiting A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875132Phase 2 · completed Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02519322Phase 2 · completed Neoadjuvant and Adjuvant Checkpoint Blockade · condition mapped CURATED_BROADER · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978443Phase 2 · terminated A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab · condition mapped ONTOLOGY_EXACT · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04244552Phase 1 · terminated A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies · condition mapped ONTOLOGY_EXACT · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243061Phase 2 · completed AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma · condition mapped ALIAS · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01395121Phase 2 · completed A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread · condition mapped ALIAS · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424515Phase 2 · completed Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577382Phase 2 · completed SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma · condition mapped ALIAS · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01120275Phase 2 · terminated Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma · condition mapped ALIAS · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470470Phase 2 · completed Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery · condition mapped ALIAS · 16 trials mapped (6 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |